Phase4 Ventures III L.P. is 10% Owner at ALBIREO PHARMA, INC. (ALBO). They have made 1 open-market trade across 1 company since 2018, most recently 2018-01-30.
CIK 0001687344
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALBO | 1,066,947 | $47.1M |
Shares reported on the most recent Form 4, priced at the 2018-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALBO | SELL | 2018-01-30 | 2018-02-07 | $34.44 | $3.4M | -4.1% | -5.0% | -18.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.